Investors

News Releases

Date Title  
Toggle Summary Tribute Pharmaceuticals Provides Update of 2014 Revenues; Anticipates Fourth Quarter Revenue Growth in Excess of 60% and Full Year Revenue Growth of Greater Than 20%
MILTON, ONTARIO -- (Marketwired) -- 01/27/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Engages BND Projects Inc. as Investor Relations Service Provider and Grants Options to Certain Officers and Directors
MILTON, ONTARIO -- (Marketwired) -- 01/29/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQB:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark Office
CHAPEL HILL, N.C. --(BUSINESS WIRE)--Feb. 4, 2015-- POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, today announced the issuance of a patent by the United States Patent and Trademark Office (USPTO) entitled “Method for Treating a
Toggle Summary Tribute Pharmaceuticals Schedules Fourth Quarter and 2014 Year End Financial Results Conference Call
MILTON, ONTARIO -- (Marketwired) -- 02/26/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Board Members and Management Exercise Series A Warrants
MILTON, ONTARIO -- (Marketwired) -- 03/02/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF) (TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Announces Strong 2014 Fourth Quarter and Year End Results
4th Quarter Revenue Up 70.5% and EBITDA Up 217% Over Comparative Periods MILTON, ONTARIO -- (Marketwired) -- 03/03/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition,
Toggle Summary POZEN Announces March 9th Webcast of Fourth Quarter and Year End 2014 Results
CHAPEL HILL, N.C. --(BUSINESS WIRE)--Mar. 4, 2015-- POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that it plans to release fourth quarter and year end 2014 results on March 9, 2015 , before the market opens.
Toggle Summary POZEN Reports Fourth Quarter and Year End 2014 Results
- Reports Annual Net Income of $19.7 Million , Including VIMOVO Royalty of $21.1 Million - - Updates Anticipated Commercialization Timing - CHAPEL HILL, N.C. --(BUSINESS WIRE)--Mar. 9, 2015-- POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms
Toggle Summary Tribute Raises US$2.7 Million Through the Exercise of Warrants
MILTON, ONTARIO -- (Marketwired) -- 03/19/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals to Participate at Laurentian Bank Securities Annual Investor Conference
MILTON, ONTARIO -- (Marketwired) -- 04/02/15 -- Tribute Pharmaceuticals Canada Inc. ("Tribute" or the "Company") (TSX VENTURE:TRX) (OTCQX:TBUFF), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the

Copyright West LLC. Minimum 15 minutes delayed.